| Followers | 843 |
| Posts | 123033 |
| Boards Moderated | 9 |
| Alias Born | 09/05/2002 |
Thursday, April 01, 2021 9:43:00 AM
https://finance.yahoo.com/news/abbotts-binaxnow-rapid-antigen-self-030600236.html
Abbott announced today it has received U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for over-the-counter, non-prescription, asymptomatic use of its BinaxNOW COVID-19 Ag Self Test for detection of COVID-19 infection. This new indication allows individuals with or without symptoms to have access to this test without a prescription. Abbott will begin shipping to major food, drug and mass merchandiser retailers in the coming weeks and expect the test to be available through some of their online store websites.
…Using the test will be simple, even for people who have never tested themselves. People will only need to perform a minimally invasive nasal swab (not the deep nasopharyngeal swab) and all materials required to perform the test (swab, test card, and reagent solution) will come in the box.
…The BinaxNOW Self Test is the same technology as the existing BinaxNOW test that has been available since August 2020 but is indicated by the FDA for serial asymptomatic testing, meaning that people should test themselves frequently.
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Recent ABT News
- Abbott secures CE Mark for world's first dual glucose-ketone sensing technology for people with diabetes • PR Newswire (US) • 05/28/2026 07:00:00 AM
- Form SD - Specialized disclosure report • Edgar (US Regulatory) • 05/27/2026 08:47:43 PM
- Abbott secures CE Mark for world's first dual glucose-ketone sensing technology for people with diabetes • PR Newswire (US) • 05/27/2026 01:00:00 PM
- ACS guideline reaffirms Abbott leadership in noninvasive colorectal cancer screening • PR Newswire (US) • 05/27/2026 11:01:00 AM
- Abbott showcases expanding evidence across its cancer diagnostics portfolio at ASCO 2026 • PR Newswire (US) • 05/26/2026 01:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/15/2026 08:15:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/29/2026 09:09:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 04/29/2026 08:42:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/29/2026 12:07:28 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/28/2026 11:58:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/28/2026 11:45:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/28/2026 11:37:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/28/2026 11:21:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/28/2026 11:14:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/28/2026 11:02:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/28/2026 10:27:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/28/2026 10:17:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/28/2026 10:01:45 PM
- Abbott receives FDA clearance and CE Mark for next-generation Ultreon™ 3.0 AI-powered coronary imaging platform • PR Newswire (US) • 04/28/2026 01:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/27/2026 10:34:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/27/2026 08:06:40 PM
- Abbott showcases strength of its technologies to address abnormal heart rhythms with late-breaking clinical data at Heart Rhythm Society 2026 • PR Newswire (US) • 04/25/2026 04:30:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 04/24/2026 08:06:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/17/2026 08:04:06 PM
- New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test • PR Newswire (US) • 04/17/2026 07:30:00 PM
